PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30922593-2	2019	Tenofovir plasma exposure has been associated with a polymorphism in SLC28A2 gene (encoding the concentrative nucleoside transporter 2, CNT2): particularly, SLC28A2 124 CT/TT genotype patients show higher plasma tenofovir concentrations, compared to CC group.	Tenofovir	0-9	solute carrier family 28 member 2	Homo sapiens	69-76	
30922593-2	2019	Tenofovir plasma exposure has been associated with a polymorphism in SLC28A2 gene (encoding the concentrative nucleoside transporter 2, CNT2): particularly, SLC28A2 124 CT/TT genotype patients show higher plasma tenofovir concentrations, compared to CC group.	Tenofovir	0-9	solute carrier family 28 member 2	Homo sapiens	96-134	
30922593-2	2019	Tenofovir plasma exposure has been associated with a polymorphism in SLC28A2 gene (encoding the concentrative nucleoside transporter 2, CNT2): particularly, SLC28A2 124 CT/TT genotype patients show higher plasma tenofovir concentrations, compared to CC group.	Tenofovir	0-9	solute carrier family 28 member 2	Homo sapiens	136-140	
30922593-2	2019	Tenofovir plasma exposure has been associated with a polymorphism in SLC28A2 gene (encoding the concentrative nucleoside transporter 2, CNT2): particularly, SLC28A2 124 CT/TT genotype patients show higher plasma tenofovir concentrations, compared to CC group.	Tenofovir	0-9	solute carrier family 28 member 2	Homo sapiens	157-164	
30922593-2	2019	Tenofovir plasma exposure has been associated with a polymorphism in SLC28A2 gene (encoding the concentrative nucleoside transporter 2, CNT2): particularly, SLC28A2 124 CT/TT genotype patients show higher plasma tenofovir concentrations, compared to CC group.	Tenofovir	212-221	solute carrier family 28 member 2	Homo sapiens	69-76	
30922593-2	2019	Tenofovir plasma exposure has been associated with a polymorphism in SLC28A2 gene (encoding the concentrative nucleoside transporter 2, CNT2): particularly, SLC28A2 124 CT/TT genotype patients show higher plasma tenofovir concentrations, compared to CC group.	Tenofovir	212-221	solute carrier family 28 member 2	Homo sapiens	96-134	
30922593-2	2019	Tenofovir plasma exposure has been associated with a polymorphism in SLC28A2 gene (encoding the concentrative nucleoside transporter 2, CNT2): particularly, SLC28A2 124 CT/TT genotype patients show higher plasma tenofovir concentrations, compared to CC group.	Tenofovir	212-221	solute carrier family 28 member 2	Homo sapiens	136-140	
30922593-2	2019	Tenofovir plasma exposure has been associated with a polymorphism in SLC28A2 gene (encoding the concentrative nucleoside transporter 2, CNT2): particularly, SLC28A2 124 CT/TT genotype patients show higher plasma tenofovir concentrations, compared to CC group.	Tenofovir	212-221	solute carrier family 28 member 2	Homo sapiens	157-164	
30922593-3	2019	In literature, substrate studies are lacking; for this reason, our aim was to understand if tenofovir and tenofovir-alafenamide are CNT2 substrates.	Tenofovir	92-101	solute carrier family 28 member 2	Homo sapiens	132-136	
26440731-5	2016	At multivariate analysis estimated creatinine clearance, protease inhibitors co-administration and SLC28A2 CT/TT genotypes were independently associated with plasma tenofovir exposure; ABCC10 GA/AA genotypes and protease inhibitor co-administration were independently associated with the urinary to plasma tenofovir ratio.	Tenofovir	165-174	solute carrier family 28 member 2	Homo sapiens	99-106	
26440731-5	2016	At multivariate analysis estimated creatinine clearance, protease inhibitors co-administration and SLC28A2 CT/TT genotypes were independently associated with plasma tenofovir exposure; ABCC10 GA/AA genotypes and protease inhibitor co-administration were independently associated with the urinary to plasma tenofovir ratio.	Tenofovir	306-315	solute carrier family 28 member 2	Homo sapiens	99-106